Changes in the vascular beta-adrenoceptor-activated signalling pathway in 2Kidney-1Clip hypertensive rats

Br J Pharmacol. 2004 Apr;141(7):1151-8. doi: 10.1038/sj.bjp.0705717. Epub 2004 Mar 8.

Abstract

1. beta-Adrenoceptor (beta-AR)-mediated vasodilation, which plays an important physiological role in the regulation of vascular tone, is decreased in two-kidney, one clip (2K-1C) renal hypertension. In this study, downstream pathways related to vascular beta-AR activation were evaluated in 2K-1C rats. 2. Relaxation responses to isoprenaline, forskolin and 8-Br-cAMP were diminished in aortas without endothelium from 2K-1C when compared to those in normotensive two kidney (2K). Basal adenosine-3',5'-monophosphate (cAMP), as well as isoprenaline-induced increase in cAMP levels, was not different between 2K and 2K-1C aortas. 3. Contractile responses to caffeine, after depletion and reloading of intracellular Ca(2+) stores, were greater in 2K-1C than in 2K. The presence of isoprenaline during the Ca(2+)-reloading period abolished the differences between groups by increasing caffeine contraction in 2K without changing this response in 2K-1C aortas. Inhibition of the sarcolemmal Ca(2+)ATPase with thapsigargin markedly attenuated isoprenaline vasodilation in both 2K and 2K-1C and abolished the differences between groups. 4. Blockade of ATP-sensitive K(+) channels (K(ATP)) channels with glibenclamide significantly decreased isoprenaline vasodilation in 2K-1C without affecting this response in 2K. Both vascular gene and protein expression of protein kinase A (PKA), as well as phosphoserine-containing proteins, were increased in 2K-1C vs 2K rats. 5. In conclusion, decreased isoprenaline vasodilation in 2K-1C hypertensive rats is related to impaired modulation of the sarcolemmal Ca(2+)ATPase activity. Moreover, K(ATP) channels may play a compensatory role on isoprenaline-induced relaxation in renal hypertension. Both Ca(2+)ATPase and K(ATP) channel functional alterations, associated with decreased beta-AR vasodilation, are paralleled by an upregulation of protein kinase A (PKA) and phosphoserine proteins expression.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 8-Bromo Cyclic Adenosine Monophosphate / pharmacology
  • Animals
  • Aorta, Thoracic / chemistry
  • Aorta, Thoracic / drug effects
  • Aorta, Thoracic / pathology
  • Caffeine / pharmacology
  • Calcium-Transporting ATPases / drug effects
  • Calcium-Transporting ATPases / metabolism
  • Colforsin / pharmacology
  • Cyclic AMP / chemistry
  • Cyclic AMP / metabolism
  • Cyclic AMP-Dependent Protein Kinases / genetics
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Disease Models, Animal*
  • Gene Expression / drug effects
  • Glyburide / pharmacology
  • Hypertension, Renovascular / physiopathology*
  • Isoproterenol / antagonists & inhibitors
  • Isoproterenol / pharmacology
  • Kidney / surgery
  • Male
  • Membrane Proteins / drug effects
  • Membrane Proteins / physiology
  • Muscle, Smooth, Vascular / chemistry
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / physiology*
  • Phenylephrine / pharmacology
  • Potassium Channels
  • RNA, Messenger
  • Rats
  • Rats, Wistar
  • Receptors, Adrenergic, beta / drug effects
  • Receptors, Adrenergic, beta / physiology*
  • Sarcolemma / drug effects
  • Sarcolemma / enzymology
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*
  • Thapsigargin / pharmacology
  • Vasoconstriction / drug effects
  • Vasodilation / drug effects

Substances

  • Membrane Proteins
  • Potassium Channels
  • RNA, Messenger
  • Receptors, Adrenergic, beta
  • mitochondrial K(ATP) channel
  • Colforsin
  • Phenylephrine
  • 8-Bromo Cyclic Adenosine Monophosphate
  • Caffeine
  • Thapsigargin
  • Cyclic AMP
  • Cyclic AMP-Dependent Protein Kinases
  • Calcium-Transporting ATPases
  • Isoproterenol
  • Glyburide